Anatol Kreitzer insider trades

Open-market stock purchases and sales by Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc, from SEC Form 4 filings since Oct 27, 2025.

Recent trades

DateStockTradeValue
Oct 15, 2026MPLT MapLight Therapeutics, IncSold$96K
Aug 17, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Aug 17, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$105K
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$533K
Jul 17, 2026MPLT MapLight Therapeutics, IncSold$7.7K
Jul 16, 2026MPLT MapLight Therapeutics, IncSold$59.6K
Jul 16, 2026MPLT MapLight Therapeutics, IncSold$274K
Jul 15, 2026MPLT MapLight Therapeutics, IncSold$200K
Jul 15, 2026MPLT MapLight Therapeutics, IncSold$167K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$242K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$867K
Apr 27, 2026MPLT MapLight Therapeutics, IncSold$239K
Apr 15, 2026MPLT MapLight Therapeutics, IncSold$88.2K
Feb 5, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Feb 5, 2026MPLT MapLight Therapeutics, IncBought (not open market)—
Jan 27, 2026MPLT MapLight Therapeutics, IncSold (not open market)$757K
Oct 27, 2025MPLT MapLight Therapeutics, IncBought (not open market)—
Oct 27, 2025MPLT MapLight Therapeutics, IncBought (not open market)—

Companies traded

  • MPLT MapLight Therapeutics, Inc: 12 sales, last Oct 15, 2026

Get free alerts when Anatol Kreitzer files a new trade →